Item 1(a). | Name of Issuer: |
Dun & Bradstreet Holdings, Inc. (“Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
101 JFK Parkway
Short Hills, NJ 07078
Item 2(a). | Name of Person Filing: |
This statement is being filed on behalf of Cannae Holdings, Inc. (“Cannae”), Cannae Holdings, LLC (“CHL”) and DNB Holdco, LLC (“DNB Holdco) (collectively, the “Reporting Persons”). DNB Holdco is a wholly-owned subsidiary of CHL, which, in turn, is a wholly-owned subsidiary of Cannae.
An agreement among the Reporting Persons on behalf of which this Schedule 13G/A is filed was previously filed as an exhibit to the original Schedule 13G filing.
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
The principal business office of each Reporting Person is:
1701 Village Center Circle
Las Vegas, NV 89134
Cannae is a Delaware corporation. CHL and DNB Holdco are Delaware limited liability companies.
Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.0001 per share (“Common Stock”), of the Issuer
Item 2(e). | CUSIP Number: 26484T106 |
(a)-(c) The responses of the Reporting Persons to Rows 5, 6, 7, 8, 9 and 11 in each of their respective cover pages which relate to the beneficial ownership of the Common Stock of the Issuer, as of December 31, 2021, are incorporated herein by reference. As of December 31, 2021, Cannae beneficially owned an aggregate of 68,052,330 shares of Common Stock (which includes all of the shares of Common Stock owned by DNB Holdco and its wholly-owned subsidiary), representing
5